Bilayer tablet农业专利-农业专业知识服务系统

专利权人:: 阿斯利康英国有限公司;阿斯利康（瑞典）有限公司;阿斯利康英國有限公司;AstraZeneca UK Limited;AstraZeneca AB

发明人:: A．阿贝贝,A．阿貝貝,K．马丁,K．馬丁,J．M．帕特尔,J．M．帕特爾,D．德赛,D．德賽,P．蒂明斯,A.阿贝贝,A.阿貝貝,K.马丁,K.馬丁,J.M.帕特尔,J.M.帕特爾,D.德赛,D.德賽,P.蒂明斯

摘要：: The present invention relates to bilayer tablet, the bilayer tablet includes melbine XR preparations, the SGLT2 inhibitor preparation as the second layer and the optional film coating being reduced as melbine extended release (XR) preparation or quality of first layer. The present invention provides the method for preparing the bilayer tablet and using bilayer tablet treatment disease relevant to SGLT2 activity or the method for obstacle.本發明涉及雙層片劑，所述雙層片劑包含作爲第一層的二甲雙胍延長釋放(XR)製劑或質量得以減小的二甲雙胍XR製劑、作爲第二層的SGLT2抑制劑製劑及任選的膜包衣。本發明提供製備所述雙層片劑的方法及使用所述雙層片劑治療與SGLT2活性相關的疾病或障礙的方法。